Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Net Income towards Common Stockholders (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Net Income towards Common Stockholders readings, the most recent being -$510000.0 for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders fell 165.81% to -$510000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$204.6 million, a 113.23% decrease, with the full-year FY2025 number at -$204.7 million, down 113.18% from a year prior.
  • Net Income towards Common Stockholders hit -$510000.0 in Q4 2025 for Tandem Diabetes Care, up from -$21.2 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $10.8 million in Q4 2021 to a low of -$130.6 million in Q1 2025.
  • Median Net Income towards Common Stockholders over the past 5 years was -$22.2 million (2024), compared with a mean of -$30.1 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: surged 161.38% in 2021 and later tumbled 944.34% in 2022.
  • Tandem Diabetes Care's Net Income towards Common Stockholders stood at $10.8 million in 2021, then crashed by 247.66% to -$15.9 million in 2022, then tumbled by 88.54% to -$30.0 million in 2023, then soared by 102.59% to $775000.0 in 2024, then tumbled by 165.81% to -$510000.0 in 2025.
  • The last three reported values for Net Income towards Common Stockholders were -$510000.0 (Q4 2025), -$21.2 million (Q3 2025), and -$52.4 million (Q2 2025) per Business Quant data.